Status:
NOT_YET_RECRUITING
Antibiotic Prophylaxis for EUS-FNA of Pancreatic Cystic Lesions
Lead Sponsor:
Société Française d'Endoscopie Digestive
Conditions:
Pancreatic Cystic Lesion
Eligibility:
All Genders
18+ years
Brief Summary
Large prospective comparative observational study in numerous reference centers in France, comparing infectious complications in patients admitted for pancreatic cystic lesions (PCL) aspiration perfor...
Detailed Description
The complication rate after EUS fine needle aspiration (EUS-FNA) for pancreatic cystic lesions (PCL) is low, around 1-3% according to various series. However, it has long been recommended to perform t...
Eligibility Criteria
Inclusion
- Patient referred for diagnostic aspiration of a pancreatic cystic lesion
- Patient aged 18 years or older
- Patient with ASA 1, ASA 2, ASA 3 status
- No participation in another concurrent clinical study
Exclusion
- Patient under 18 years old
- Patient with ASA 4 or ASA 5 status
- Pregnant woman
- Patient with coagulation disorders preventing the performance of an EUS-FNA: PT \< 50%, platelets \< 50,000/mm³, current effective anticoagulation, ongoing clopidogrel, prasugrel, or ticagrelor treatment
- Patient unable to personally express non-opposition or legally protected adult
Key Trial Info
Start Date :
September 15 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 15 2027
Estimated Enrollment :
1702 Patients enrolled
Trial Details
Trial ID
NCT06535490
Start Date
September 15 2024
End Date
October 15 2027
Last Update
August 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinique Paris-Bercy
Charenton-le-Pont, France, 94220